Fed. Circ. Revives Orexo's Opioid Addiction Treatment Patent

The Federal Circuit ruled Monday that generic-drug maker Actavis Elizabeth LLC had not shown part of an Orexo AB patent covering the opioid addiction treatment Zubsolv was invalid, overturning a ruling...

Already a subscriber? Click here to view full article